| ²é¿´: 2846 | »Ø¸´: 13 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
³ÕÃÎäìÏæÄ¾³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
2013Äê4Ô·ÝÈ«ÇòÒ©Æó½»Ò×ÁÁµã ÒÑÓÐ8È˲ÎÓë
|
||
|
1.Bind TherapeuticsÄÉÃ×Ò©Îï¼¼Êõƽ̨±¶ÊÜÇàíù 4ÔÂ3ÈÕ£¬Pfizer Inc.ÓëBind Therapeutics´ï³ÉÐÒ飬¹²Í¬¿ª·¢ÐÂÐͰÐÏòÒ©ÎïAccurins™£¬PfizerÖ§¸¶Ô¤¸¶¿î5000ÍòÃÀÔª£¬Àï³Ì½ð1.6ÒÚÃÀÔª¡£ 4ÔÂ22ÈÕ£¬AstraZenecaÓëBind Therapeutics´ï³ÉÐÒ飬¹²Í¬¿ª·¢°ÐÏò¿¹°©Ò©ÎïAccurin™£¬AstraZenecaÖ§¸¶Ô¤¸¶¿î6900ÍòÃÀÔª£¬Àï³Ì½ð1.3ÒÚÃÀÔª¡£ Accurin™ÊÇÔÚÄÉÃ×Ò©Îï¼¼Êõƽ̨£¨Medicinal Nanoengineering platform£©»ù´¡ÉÏ¿ª·¢µÄÒ»ÖÖ°ÐÏò¼¼Êõ£¬¿ÉÒÔʹҩÎïÑ¡ÔñÐÔŨ¼¯ÓÚ²¡±ä×éÖ¯ºÍϸ°û£¬½µµÍÒ©Îï¶¾ÐÔ¡£ 2.AstraZenecaƵƵ³öÊÖ 4ÔÂ4ÈÕ£¬AstraZenecaÊÕ¹ºAlphaCore Pharma£¬½»Ò×¶îδ¹«¿ª¡£AlphaCoreÓÐÒ»ÔÚÑнµÑªÖ¬Ò©ÎïACP-501£¨ÖØ×éLCATø£©£¬IÆÚÁÙ´²ÄÍÊÜÐÔÁ¼ºÃ£¬ÎÞÃ÷ÏÔ¸±×÷Óã¬ÄÜÏÔÖøÔö¼ÓHDL-C¡£ 4ÔÂ22ÈÕ£¬AstraZenecaÓëHorizon Discovery´ï³ÉºÏ×÷ÐÒ飬ºÏ×÷¿ª·¢HD-001£¬AstraZenecaÖ§¸¶7500ÍòÃÀÔªÔ¤¸¶¿î¼°Àï³Ì½ð¡£HD-001ÊÇÒ»ÖÖÐÂÐͼ¤Ã¸ÒÖÖÆ¼Á£¬ÓÃÓÚÖÎÁƽ᳦°©ºÍ·Î°©£¬ÊôÓÚFirst-in-Class£¬Ä¿Ç°´¦ÓÚÒ©Îï·¢Ïֽ׶Σ¬ÉÐδ½øÈëÁÙ´²¡£ÖµµÃ×¢ÒâµÄÊÇ£¬¸ÃÒ©¶ÔK-Ras±äÒìÐͰ©Ö¢ÓÐЧ¡£ 4ÔÂ23ÈÕ£¬AstraZenecaÓëAlchemia Limited´ï³ÉºÏ×÷ÐÒ飬AstraZeneca½«»ñµÃDiversity Scanning Array¼°Ïà¹ØVersatile Assembly on Stable Templates»¯Ñ§Æ½Ì¨µÄʹÓÃȨ£¬ÓÃÓÚ¿ª·¢Éæ¼°¶à¸ö°ÐµãµÄС·Ö×ÓÒ©ÎAstraZenecaÖ§¸¶2.4ÒÚÃÀÔª¼°Àï³Ì½ð¡£Diversity Scanning Arrayº¬ÓÐ14000+»¯ºÏÎïµÄ3DÐÎ×´¼°ëÄÄ£ÄâÑ§ÌØÕ÷£¬ÔÚ¸ßͨÁ¿É¸Ñ¡ÖÐÆ¥Åä°ÐµãËùÐèµÄÐÎ×´ºÍ½áºÏÌØÕ÷¡£ 3ÔÂ21ÈÕ£¬AstraZenecaÓëModerna Therapeutics´ï³ÉºÏ×÷ÐÒ飬¹²Í¬¿ª·¢mRNAÒ©ÎAstraZenecaÖ§¸¶Ô¤¸¶¿î2.4ÒÚÃÀÔª£¬Àï³Ì½ð1.8ÒÚÃÀÔª¡£Í¨¹ý½«È˹¤ºÏ³ÉmRNAµ¼Èëϸ°û£¬²úÉú¸÷ÖÖËùÐèµ°°×ÖÊ£¬Ä¿Ç°ÉÐδ½øÈëÁÙ´²Ñо¿£¬Õâ³ÉΪ×î´óµÄÔçÆÚÑо¿Ðí¿ÉÐÒéÖ®Ò»¡£ 3.ƽ̨¼¼ÊõÊ®·Ö»ð±¬ 4ÔÂ8ÈÕ£¬ÓÐ11´ó½»Ò×Éæ¼°Æ½Ì¨¼¼Êõ£¬ÕâÀïÁоÙËĸö£º Ambrx/Astellas£º¿¹ÌåżÁªÒ©ÎïÆ½Ì¨£¬1500ÍòÃÀÔªÔ¤¸¶¿î£¬2.85ÒÚÃÀÔªÀï³Ì½ð¡£ Isis/Roche£º·´Òå¹ÑºËÜÕËáÒ©ÎïÆ½Ì¨£¬3000ÍòÃÀÔªÔ¤¸¶¿î£¬3.62ÒÚÃÀÔªÀï³Ì½ð¡£ Ra Pharmacuticals/Merck & Co£ºCyclomimetics£¨ëÄÀàËÆÎ¼æ¾ßС·Ö×Ó¡¢¿¹ÌåÌØÐÔ£¬µ°°×µ°°×Ï໥×÷Óã©£¬2ÒÚÃÀÔªÔ¤¸¶¿î¼°Àï³Ì½ð¡£ Santaris/BMS£ºËøºËËáÒ©ÎïÆ½Ì¨£¬Ô¤¸¶¿î1000ÍòÃÀÔª£¬Àï³Ì½ð9000ÍòÃÀÔª 4.Pfizer/MerckǿǿÁªºÏ ÔÚÇ¿ÉúCanagliflozin˳Àû»ñµÃFDAÅú×¼ºó£¬MerckÓÃ6000ÍòÃÀÔª±§ÉÏ»ÔÈð´óÍÈ£¬¹²Í¬¿ª·¢SGLT2ÒÖÖÆ¼ÁErtugliflozin (PF-04971729)£¬º´ÎÀÆä¿Ú·þ½µÌÇÒ©µÄ°ÔÖ÷µØÎ»¡£ [ Last edited by ³ÕÃÎäìÏæ on 2013-5-9 at 12:28 ] |
» ²ÂÄãϲ»¶
ÊDz»ÊÇÏÖÔÚ¿¼²©¶¼ÊÇÍÆ¼öÖÆ£¿»òÕßÊÇÒѾÄÚ¶¨ÁË£¿»¹ÓÐͨ¹ý¿¼ÊÔÕв©Ê¿µÄѧУÂð£¿
ÒѾÓÐ39È˻ظ´
Å©²úÆ·ÖÐũҩ¼à²âµÄÃâÒß´«¸ÐÆ÷µÄÒÉÎÊ
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ98È˻ظ´
ÄÉÃ×´«¸ÐÆ÷¼à²âũҩ²ÐÁôµÄÒÉ»ó
ÒѾÓÐ0È˻ظ´
ËÓÐÈËÎÀ°æ ¡¶¶¾Àíѧ»ù´¡¡·µÚÆß°æÊé¼®
ÒѾÓÐ0È˻ظ´
26ÓÐûÓÐÀÏʦÏëÊÕ×ö¶¨Á¿Ò©ÀíµÄѧÉú°¡
ÒѾÓÐ3È˻ظ´
26¿¼²©ÉêÇë ѧorר
ÒѾÓÐ15È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
lymfrank
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 5051.8
- É¢½ð: 10
- ºì»¨: 2
- Ìû×Ó: 560
- ÔÚÏß: 223.6Сʱ
- ³æºÅ: 218012
- ×¢²á: 2006-03-12
- ÐÔ±ð: MM
- רҵ: Ò©Îﻯѧ

11Â¥2013-05-11 08:46:00
als3411
ľ³æ (ÕýʽдÊÖ)
Ãñ¹¤
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 3507.6
- É¢½ð: 55
- ºì»¨: 1
- Ìû×Ó: 484
- ÔÚÏß: 239.1Сʱ
- ³æºÅ: 1206161
- ×¢²á: 2011-02-18
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
| ¸ÒÎÊÂ¥Ö÷£¬´ÓÄĶù¿ÉÒÔ¿´µ½ÕâЩ×îÐÂÏûÏ¢ÄØ£¿ |

3Â¥2013-05-09 09:27:31
ulfasss
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 1570.8
- ºì»¨: 1
- Ìû×Ó: 137
- ÔÚÏß: 105.5Сʱ
- ³æºÅ: 355841
- ×¢²á: 2007-04-25
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ

4Â¥2013-05-09 09:32:45
Ò©µÀÈË
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
¾»ÓÉ»àÉú£¬Ã÷´Ó霳ö
-

ר¼Ò¾Ñé: +71 - DRDEPI: 1
- Ó¦Öú: 38 (СѧÉú)
- ¹ó±ö: 6.92
- ½ð±Ò: 27026.1
- É¢½ð: 9994
- ºì»¨: 143
- ɳ·¢: 178
- Ìû×Ó: 25008
- ÔÚÏß: 1356.1Сʱ
- ³æºÅ: 336426
- ×¢²á: 2007-04-01
- ÐÔ±ð: GG
- רҵ: µÀ½Ì
- ¹ÜϽ: ½ðÈÚͶ×Ê

6Â¥2013-05-09 17:10:34













»Ø¸´´ËÂ¥

10